Article Versions Notes

Jiang Y, Zhang Y, Zhu Z, Huang Y, Zhou D, Liu J, Li C, Chen X, Kang D, Wang S, et al. Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial. Journal of Clinical Medicine. 2022; 11(23):6951. https://doi.org/10.3390/jcm11236951

Jiang, Yingying, Yujun Zhang, Zhaoqiong Zhu, Yidan Huang, Dachun Zhou, Jingchen Liu, Chaoyu Li, Xiangdong Chen, Dingxin Kang, Shoushi Wang, and et al. 2022. "Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial" Journal of Clinical Medicine 11, no. 23: 6951. https://doi.org/10.3390/jcm11236951

Jiang, Y., Zhang, Y., Zhu, Z., Huang, Y., Zhou, D., Liu, J., Li, C., Chen, X., Kang, D., Wang, S., Liu, J., Liu, B., & Zhang, W. (2022). Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial. Journal of Clinical Medicine, 11(23), 6951. https://doi.org/10.3390/jcm11236951